News
The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback